HCA Red Flag: Novonesis raises guidance and initiates a 1 BEUR share buyback (AI)
HC Andersen Capital
Summary
- Novonesis raised its full-year growth guidance to 7% to 8% and announced a 1 BEUR share buyback, despite its largest division, Agriculture, Energy & Tech, underperforming with 7% growth against an expected 8.6%.
- Net profit excluding one-off costs fell short of expectations at 179.4 MEUR, with net financial expenses nearly doubling due to a 1.7 BEUR bond issuance.
- The company achieved 8% growth in the first half, but the new guidance suggests a weaker second half, attributed to US tariffs and inventory adjustments.
- Household Care exceeded expectations with 12% organic growth, significantly contributing to the group's overall growth of 9% versus the anticipated 7.4%.
This content is generated by AI. You can give feedback on it in the Inderes forum.
Automatic translation: Originally published in undefined 19/08/2026, 16:24 GMT. Give feedback here.
Red Flag · First reading of the financial statements · AI-generated content
Novonesis (NSIS B) · Q2 2026 · August 19
The share price has risen 11% in three months and is approximately 4% below its peak for the past twelve months
Overall assessment
Positive assessment
Positive assessmentBalancedNegative assessment
Expect a positive opening. Novonesis raised its full-year growth guidance to 7% to 8% vs. the 6.9% analysts expected, and announced its first share buyback of 1 BEUR. The counterweight is the largest division, Agriculture, Energy & Tech, which grew 7% when 8.6% was expected.
Red flags in the financial statements
Agriculture, Energy & Tech disappoints again
Actual 7% · Expected 8.6% organic growth
The company's largest division, which accounts for about one-third of sales, grew 7%, while analysts expected 8.6%. Plant, the crop business, declined again due to a weak US agricultural economy, and Novonesis still does not disclose growth rates for Plant and Tech, a figure analysts have requested in three consecutive conference calls.
Sales met expectations, but the bottom line did not follow
Actual 179.4 MEUR · Expected 182.0 MEUR
Net profit excluding one-off costs was below analysts' expectations, even though sales were higher than expected. Net financial expenses almost doubled from the previous year to 29.9 MEUR, as the 1.7 BEUR bond issuance from March is now fully reflected.
The new range still points to a weaker second half
Full year 7% to 8% · Q2 was 9%
With 8% growth already achieved in the first half, the raised guidance requires approximately 6% to 8% in the second half, which is below the 9% just delivered. Novonesis points to two reasons: US tariffs, which are refunded to customers, and the inventory build-up at a customer in Animal reversing again.
Positive signs in the financial statements
Guidance raised for the first time in a year
New: 7% to 8% · Previous: 5% to 7%
Organic growth, i.e., growth excluding acquisitions and currency effects, is now expected to be 7% to 8% in 2026 vs. the 6.9% analysts had in their models. At the same time, the margin expectation moved up to the high end of the 37% to 38% range.
First share buyback, and the main shareholder sells along
New: 1 BEUR, H2 2026 to 2029
The Board of Directors has approved a first multi-year share buyback of 1 BEUR, where the vast majority of the shares will be canceled. Novo Holdings, the controlling owner, will sell shares into the program to maintain an ownership stake of around 25.5%, so that the buyback does not increase the main shareholder's influence.
Household Care delivered more than double what was expected
Actual 12% · Expected 5.6% organic growth
Household Care, the enzymes for detergents, grew 12%, while analysts expected 5.6%, with growth markets being the strongest. This is the clearest answer so far to fears that a weaker consumer was starting to bite, and it boosted the group's growth to 9% vs. the expected 7.4%.
Disclaimer: This is an HCA AI-generated research commentary based solely on the company's published financial statements. The commentary does not constitute investment advice and should not be the sole basis for investment decisions. Investing in shares involves a risk of loss. Seek professional advice. /HC Andersen Capital, 18.19, 19.08.2026